( Toronto:NPC )

News from Allon Therapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

10 Jul, 2013, 16:29 ET Allon Receives Court Approval for Proposal and Reorganization

VANCOUVER, July 10, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") refers to its news release dated May 30, 2013...


07 Jun, 2013, 13:30 ET Allon Provides Update to its Proposal and Reorganization

VANCOUVER, June 7, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") refers to its news release dated May 30, 2013...


30 May, 2013, 09:00 ET Allon Announces the Filing of a Proposal with Creditors and Reorganization

VANCOUVER, May 30, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") announced today that it has filed a proposal (the...


18 Dec, 2012, 13:48 ET Allon announces PSP clinical trial results

VANCOUVER, Dec. 18, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that its pivotal clinical trial evaluating its lead...


05 Dec, 2012, 08:30 ET The United States, New Zealand & Mexico Issue Patent for New Allon Platform

VANCOUVER, Dec. 5, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that the United States, New Zealand and Mexican patent...


29 Nov, 2012, 08:30 ET Allon selected as Top 10 partnering prospect by CNS experts

VANCOUVER, Nov. 29, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) was selected as one of the "Top 10 CNS Licensing Prospects" and will...


22 Nov, 2012, 14:08 ET Allon files preliminary shelf prospectus

VANCOUVER, Nov. 22, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) has filed a preliminary short form base shelf prospectus (the "Shelf...


13 Nov, 2012, 08:30 ET Patient treatment completed in pivotal trial evaluating Allon's davunetide

VANCOUVER, Nov. 13, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that patient treatment has been completed in the...


05 Nov, 2012, 19:30 ET Allon Therapeutics releases Q3 operating results and provides corporate update

VANCOUVER, Nov. 5, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three and...


10 Oct, 2012, 08:30 ET Allon's CEO presenting at 2012 BIO Investor Forum and Updating Guidance

VANCOUVER, Oct. 10, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the...


11 Sep, 2012, 08:30 ET Allon's CEO presenting at 2012 Rodman and Renshaw Global Conference

VANCOUVER, Sept. 11, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the...


07 Aug, 2012, 17:00 ET Allon Therapeutics releases Q2 operating results and provides corporate update

VANCOUVER, Aug. 7, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three and...


16 Jul, 2012, 08:30 ET Allon Presents Baseline Data from PSP Clinical Trial to Alzheimer's Conference

VANCOUVER, July 16, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced that data presented at the Alzheimer's Association...


21 Jun, 2012, 08:30 ET Allon CEO updates Bloom Burton & Co. Healthcare Investor Conference

VANCOUVER, June 21, 2012 /PRNewswire/ - Allon Therapeutics Inc. TSX: NPC President and CEO Gordon McCauley is presenting an update of the Company's...


14 Jun, 2012, 08:30 ET Allon Therapeutics shareholders approve $10-million private placement

VANCOUVER, June 14, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) said today that its shareholders have approved the terms of the $10...


30 May, 2012, 08:30 ET Allon CEO updates BioFinance Conference on pivotal trial progress and DSMB recommendation

VANCOUVER, May 30, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley is presenting an update of the...


14 May, 2012, 08:30 ET New Allon research presented at leading scientific symposium

VANCOUVER, May 14, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that a presentation given May 12 at the prestigious 12th...


02 May, 2012, 08:00 ET Allon Therapeutics announces completion of $10 million private placement

VANCOUVER, May 2, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that it has completed the previously announced brokered...


16 Apr, 2012, 08:00 ET Allon Therapeutics announces private placement

VANCOUVER, April 16, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that  it plans to complete a brokered private...


28 Mar, 2012, 08:30 ET Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs

VANCOUVER, March 28, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that it has been granted a U.S. patent that covers the...


12 Mar, 2012, 08:30 ET Allon advances Parkinson's disease program

VANCOUVER, March 12, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today the completion of its first phase of work in a...


29 Feb, 2012, 08:30 ET New publication describes Allon's davunetide as the most advanced global drug candidate for PSP

VANCOUVER, Feb. 29, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that a review of davunetide as a potential treatment for...


13 Feb, 2012, 08:30 ET Allon's Data Safety Monitoring Board recommends continuation of pivotal clinical trial

VANCOUVER, Feb. 13, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the...


07 Mar, 2011, 13:20 ET Allon Therapeutics' CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com

Allon Therapeutics Inc. (TSX: NPC), today announced that their March 3rd RetailInvestorConferences.com presentation is available for on-demand...


28 Feb, 2011, 09:00 ET Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd

Allon Therapeutics Inc. (TSX: NPC), today announced that Gordon C. McCauley, President and CEO, will present at...